Biotech SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm July 1, 2022
Biotech Cyclacel Pharmaceuticals Achieves Key Business Objectives in First Half of 2022 and Continues to Advance Clinical Pipeline June 30, 2022
Biotech Evofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent From USPTO June 30, 2022
Biotech Daré Bioscience Announces Closing of Global License Agreement with Organon to Commercialize XACIATO(TM) (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis June 30, 2022